Understanding Bullish Leveraged ETFs – Part 1
by Leslie N. Masonson, MBA In 2006, a handful of equity leveraged ETFs came to market. And over the years the number has expanded to the current 154 with assets under management of $70.3 billion with an average expense ratio of 1.03%. They come with various levels of leverage from 1.5, 2 and 3 times their underlying benchmark. There [...]
Tesla Drops More Than 15% on Poor Earnings and Production Concerns: Time to Sell TSLA Stock?
Tesla (TSLA) delivered earnings for the third quarter yesterday, sending shares more than 10% lower in a single day and reaching its lowest point in more than 2 months. The stock continued that trajectory into Friday’s trading session and is down 5% so far this morning. While revenue did climb 13% year over year for the quarter, the $23.4 [...]
Is it Easy to Predict Trends in the Stock Market? How to Predict Stock Market Trends With Precision
Every investor, from beginner swing traders to seasoned professionals, yearns for the ability to foresee the market's next move. After all, if you know which way a stock’s price is heading, executing your trades accordingly becomes a whole lot easier and less stressful! But is it easy to predict trends in the stock market? Is it even possible to learn [...]
Netflix Gains 15% on Profitability Boost, Subscriber Growth: Is it Time to Buy, Though?
Streaming giant Netflix (NFLX) is up 15% so far in Thursday morning’s trading session after the company delivered solid third-quarter earnings, which featured a boost to both profitability and subscribers. We’ve talked about the company’s efforts to crack down on password sharing in the past and what it could mean for the streamer financially. And now, Netflix is reaping [...]
United Airlines Drops on Warnings of Profit Problems: It May Be Time to Sell This Stock
United Airlines (UAL) dropped more than 8% in Wednesday morning’s trading session after the company issued a grave profit warning along with its 3rd quarter earnings results. Adjusted earnings per share came in at $3.65 compared to the $3.35 analysts were looking for. Revenue narrowly outperformed the estimate at $14.48 billion compared to $14.44 billion. This was an improvement [...]
Johnson & Johnson Beats Earnings & Raises Forecast – So Why is the Stock Falling?
Yesterday, we highlighted Pfizer’s challenges in pivoting as a post-pandemic company. Today, its competitor Johnson & Johnson (JNJ) reported earnings itself. But, Johnson & Johnson painted an entirely different picture - beating out the earnings estimate on the top and bottom line while raising the forecast for the remainder of the year. The company delivered 3rd quarter revenue of [...]
